TY  - JOUR 
AU  - Mora, Elvira
AU  - Fox, María Laura
AU  - Lemes, Angelina
AU  - Velasco, Beatriz
AU  - Hernández Rivas, Jesús María
PY  - 2025
UR  - http://hdl.handle.net/10366/172006
AB  - [EN]Hypereosinophilic syndrome (HES) is a rare condition characterized by elevated eosinophil levels and related symptoms of eosinophil-mediated organ damage. We reviewed the effectiveness and safety of mepolizumab for the treatment of HES. A scoping...
LA  - eng
KW  - Antibodies, Monoclonal, Humanized
KW  - Hypereosinophilic Syndrome
KW  - Humans
KW  - Eosinophils
KW  - Glucocorticoids
KW  - Treatment Outcome
KW  - Glucocorticoids
KW  - Hypereosinophilic Syndrome
KW  - Eosinophils
KW  - Antibodies
KW  - Treatment Outcome
KW  - Humans
TI  - Mepolizumab for hypereosinophilic syndrome: effectiveness and safety from real-world evidence
DO  - 10.3389/fimmu.2025.1704077
T2  - Frontiers in immunology
VL  - 16
M2  - 1704077
ER  -